CS, an enzyme of the tricarboxylic acid cycle, has been recognized as an important factor in the progression of cancer pathogenesis and was found to be a marker of chemoresistance in non-small-cell lung carcinoma [27]. The gene discussed is CS; the disease is non-small cell lung carcinoma.